Proposition - PharmXpert Academy

374 2007 Korea Pharmaceutical Industry Directory
government-donated research and development projects of Ministry of Science
and Technology, Ministry of Health and Welfare, Ministry of Commerce, Industry,
and Energy, etc.
- Gene re-combination proteins for treatment of osteoporosis
- Gene re-combination anti-coagulant proteins
- Antibiotics using fermentation process of microorganisms
- Peptide antibiotics
The priority of the company is to promote development of competitive
high-quality raw material medicines through creation of new processes based on
accumulated know-how for the aim of development of high value added raw
materials using synthesis of new raw materials and chirotechnology. Also, in
combination with the above, the company puts efforts into maximization of
efficiency for synthetic processes based on operation of KG-lab, internal analysis
system, etc.
- Cilastatin sodium and intermediates
- Raw material for treatment of dementia
- New treatment agents of wound: Wound treatment agents of which
candidate materials are Asiaticoside derivatives
- Analgesics in the alkaloid group: New analgesics in the oripavine group